The global lithotripsy market is experiencing notable growth driven by the rising prevalence of kidney stones and increasing demand for minimally invasive urological procedures. The market was valued at US$ 1.4 billion in 2023 and is projected to reach US$ 2.3 billion by 2031, expanding at a compound annual growth rate (CAGR) of 6.6% during 2023–2031. Increasing awareness of noninvasive treatment options, technological advancements in lithotripsy devices, and improved healthcare infrastructure are key factors contributing to market expansion. A major highlight of this industry is Market Share Analysis by Geography, as regional healthcare systems, reimbursement policies, and patient demographics significantly influence market growth and adoption of lithotripsy technologies worldwide.

Lithotripsy is a widely adopted procedure used to break kidney and urinary tract stones into smaller fragments that can pass naturally through the urinary system. The rising global burden of urolithiasis, lifestyle changes, and growing geriatric populations are increasing the number of lithotripsy procedures globally. In addition, hospitals and specialized urology clinics are investing in advanced lithotripsy systems to improve patient outcomes and reduce recovery time. The increasing shift toward outpatient procedures and minimally invasive therapies is also fueling demand for advanced lithotripsy devices across healthcare facilities.

Download Sample PDF Report:
https://www.theinsightpartners.com/sample/TIPRE00039180

Market Segmentation Overview

The lithotripsy market is broadly segmented based on product type, application, and end user, each contributing to the overall growth of the industry.

By Product Type

Based on product type, the market is categorized into extracorporeal lithotripsy devices and intracorporeal lithotripsy devices. Among these, extracorporeal shock wave lithotripsy (ESWL) devices hold the largest share of the global market due to their noninvasive nature and high adoption in hospitals. These devices utilize shock waves to break stones without requiring surgical intervention.

Intracorporeal lithotripsy devices are further segmented into:

• Laser lithotripsy
• Electrohydraulic lithotripsy
• Ultrasonic lithotripsy
• Mechanical lithotripsy

Laser lithotripsy, particularly holmium laser technology, is gaining traction due to its precision and effectiveness in treating complex stones. Continuous technological improvements in imaging and laser systems are expected to drive the growth of this segment during the forecast period.

By Application

In terms of application, the lithotripsy market is segmented into:

• Kidney stones
• Ureteral stones
• Bile duct stones
• Pancreatic stones
• Bladder stones

Among these, kidney stone treatment accounted for the largest market share in 2023 and is expected to maintain its dominance through 2031. The increasing incidence of kidney stones due to dietary habits, obesity, and dehydration has significantly increased demand for lithotripsy procedures worldwide. Moreover, advanced lithotripsy technologies enable faster stone fragmentation and improved patient outcomes, encouraging hospitals and clinics to adopt these systems.

By End User

Based on end users, the market is segmented into:

• Hospitals
• Clinics
• Ambulatory surgical centers

Hospitals represent the largest share of the market due to the availability of advanced diagnostic equipment, skilled healthcare professionals, and higher patient volumes. However, ambulatory surgical centers are emerging as fast-growing end users because they provide cost-effective and convenient outpatient treatments.

Market Share Analysis by Geography

Geographically, the lithotripsy market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Each region contributes uniquely to the market based on healthcare infrastructure, technological adoption, and patient demographics.

North America

North America holds the largest share of the global lithotripsy market, driven by well-established healthcare systems, high healthcare expenditure, and widespread adoption of advanced medical technologies. The United States accounts for a significant portion of the regional market due to the high prevalence of kidney stones and the presence of leading medical device manufacturers. Advanced outpatient surgical centers and favorable reimbursement policies also support the adoption of lithotripsy devices across the region.

Europe

Europe represents the second-largest market for lithotripsy devices, supported by strong healthcare infrastructure and growing awareness about minimally invasive treatment methods. Countries such as Germany, the UK, and France are key contributors to regional market growth due to technological advancements and increased investments in urology healthcare services.

Asia Pacific

The Asia Pacific region is expected to register the highest CAGR during the forecast period. Rapid improvements in healthcare infrastructure, increasing healthcare expenditure, and a large patient population are driving demand for lithotripsy procedures in countries such as China, India, and Japan. Additionally, the rising prevalence of kidney stones in developing economies and increasing access to modern healthcare facilities are accelerating regional market growth.

Middle East & Africa and South & Central America

These regions are experiencing gradual growth due to expanding healthcare infrastructure and growing awareness about advanced urology treatments. Government initiatives to improve healthcare services and increasing investments in medical technology are expected to create new growth opportunities for the lithotripsy market in the coming years.

Key Players in the Lithotripsy Market

The global lithotripsy market is highly competitive, with several prominent medical device companies focusing on product innovation, strategic partnerships, and geographic expansion. Some of the leading players operating in the market include:

• EDAP TMS
• DirexGroup
• Becton, Dickinson and Company
• Olympus Corporation
• Cook Medical LLC
• Dornier MedTech (Advanced MedTech)
• Storz Medical AG
• Boston Scientific Corporation
• Novamedtek
• Elmed Medical Systems
• Karl Storz SE & Co. KG
• Siemens Healthineers AG

These companies are actively investing in research and development to introduce technologically advanced lithotripsy systems that enhance treatment precision and patient safety.

Future Outlook

The future of the lithotripsy market looks promising as healthcare providers increasingly adopt noninvasive and minimally invasive treatment methods. Technological advancements such as laser lithotripsy systems, improved imaging technologies, and portable lithotripsy devices are expected to transform the treatment landscape. In addition, the rising prevalence of kidney stones and the expansion of healthcare infrastructure in emerging economies will continue to drive market growth through 2031.

Trending Related Reports:

·         Lithotripsy Devices Market Expert Analysis by Size and Share 2031

·         Extracorporeal Lithotripsy Market Report 2031 by Segments, Geography, Dynamics

·         Extracorporeal Shock Wave Lithotripsy Market Strategies, Top Players, Growth Opportunities

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
If you have any queries about this report or if you would like further information, please get in touch with us:
Website: https://www.theinsightpartners.com/

Phone: +1-646-491-9876
Also Available in : Korean|German|Japanese|French|Chinese|Italian|Spanish